Languages
Pages
Legal
Explore all categories to find your favorite topic
Assessing the Effectiveness of Compliance Programs 326746v1 Eve Costopoulos, Esq. Senior Legal Director - Compliance Schering-Plough Corporation Overview Standards for Compliance…
Population Enrichment Designs Case Study of a Large Multinational Trial Harvard Schering-Plough Workshop Boston, 29 May 2009 Cyrus R. Mehta, Ph.D Cytel Corporation and Harvard…
Slide 1Peto Trend Test: Investigating The Impact Of Tumor Misclassification FDA/Industry Workshop Amrik Shah - Schering-Plough Melody Goodman - Harvard University Slide 2…
Slide 1 Here comes PCT David Gilbert, MD Slide 2 Disclosures Advisory/Consultant: Pfizer, Bayer, Schering-Plough, Pacific Bioscience, Advanced Life Science, Wyeth, Roche,…
Slide 1 Summer Management of Beef Calves Mark F. Spire, DVM, MS, DACT Schering-Plough Animal Health Technical Services Manager Manhattan, KS Slide 2 Summer Management 28…
www.oracle.com www.touchbriefings.com B R I E F I N G S Clinical Trial Management: Enabling Operational Efficiency Contents: New Challenges Call for Innovative Approaches…
Systemische Pilzinfektionen: Eine Einführung Prof. Dr. med. Andreas H. Groll Infektiologisches Forschungsprogramm Knochenmarktransplantations-Zentrum und Pädiatrische Hämatologie/Onkologie…
Selektivnà kinázové inhibitory na bázi pyrazolo[1,5-a]pyrimidinu Dr. Kamil Paruch Schering-Plough Research Institute, Kenilworth, NJ, USA Ãstav chemie, Masarykova…
Track III-A Creating Relationships with Prescription Drug Plans and Managed Care Organizations David L. Ralston Legal Director Schering-Plough Corporation Part D is for Dollars…
Slide 1 Disclosure Dr. Bhatt has received honoraria from: Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, Millennium, Schering Plough, sanofi aventis, The Medicines Company.…
The Pharma, Biotech and Device Colloquium Applying a Risk-Based Compliance Model to Clinical Operations Michael Swiatocha Schering-Plough Corporation June 8, 2004 * Agenda…
Document Name
ODAC in refractory Anaplastic Astrocytoma (94-123) Post-approval commitment study (98-13) commitment study Schering-Plough development programs with temozolomide in primary
LEAD GENERATION APPROACHES IN DRUG DISCOVERY Zoran Rankovic Schering-Plough Corporation Newhouse Lanarkshire UK Richard Morphy Schering-Plough Corporation Newhouse Lanarkshire…
Mass Spectrometry and Proteomics - Application of Proteomics Research for New Drug Targets StudyYan-Hui LiuStructural Chemistry/Mass SpectrometrySchering-Plough Research…
Reunión de Departamento Médico 6-8 octubre 2003 Hotel Vall Ferrera, ÀreuSchering-Plough Agenda Schering-Plough orientadas a la contención del
Guide to Alcohol-Free Products & Incidental Exposure Index & Products Containing Alcohol Reprinted By Permission Of The Talbott Recovery Campus HOW TO USE THIS GUIDE…
Conflicts of Interest: Understanding the Impact of Relationships with Industry Douglas S. Diekema MD, MPH Center for Pediatric Bioethics, SCRI Professor of Pediatrics University…
2013 Retiree Benefits Annual Enrollment FOR LEGACY SCHERING-PLOUGH RETIREES Welcome to the 2013 Retiree Benefits Annual Enrollment OCT. 19, 2012—NOV. 9, 2012 October 2012…